102 related articles for article (PubMed ID: 28453457)
1. Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer.
Choi B; Lee HJ; Min J; Choe HN; Choi YS; Son YG; Ahn HS; Suh YS; Goldenring JR; Yang HK
Cancer Biomark; 2017 Jul; 19(3):231-239. PubMed ID: 28453457
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
Lee HJ; Nam KT; Park HS; Kim MA; Lafleur BJ; Aburatani H; Yang HK; Kim WH; Goldenring JR
Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
[TBL] [Abstract][Full Text] [Related]
3. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
Ito R; Oue N; Yoshida K; Kunimitsu K; Nakayama H; Nakachi K; Yasui W
Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349
[TBL] [Abstract][Full Text] [Related]
5. Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer.
Matsusaka K; Ushiku T; Urabe M; Fukuyo M; Abe H; Ishikawa S; Seto Y; Aburatani H; Hamakubo T; Kaneda A; Fukayama M
Oncotarget; 2016 Sep; 7(39):64168-64181. PubMed ID: 27580354
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population.
Latorre G; Pizarro M; Ford JS; Gándara V; Muñoz G; Araya JC; Bellolio E; Villaseca M; Fuentes-López E; Cortés P; Rollán A; Bufadel ME; Araya R; Vargas JI; Espino A; Sharp A; Agüero C; Donoso A; Bresky G; Pedrero P; Rueda C; Calvo A; Odagaki T; Moriyama T; Ishida T; Parra-Blanco A; Camargo MC; González R; Corvalán AH; Riquelme A;
Gastroenterol Hepatol; 2023; 46(6):411-418. PubMed ID: 35580739
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z
Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622
[TBL] [Abstract][Full Text] [Related]
8. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
9. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis.
Zhang CX; Wu CT; Xiao L; Tang SH
Biomarkers; 2021 Mar; 26(2):95-102. PubMed ID: 33401971
[TBL] [Abstract][Full Text] [Related]
12. LI-cadherin: a marker of gastric metaplasia and neoplasia.
Grötzinger C; Kneifel J; Patschan D; Schnoy N; Anagnostopoulos I; Faiss S; Tauber R; Wiedenmann B; Gessner R
Gut; 2001 Jul; 49(1):73-81. PubMed ID: 11413113
[TBL] [Abstract][Full Text] [Related]
13. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.
Suh YS; Lee HJ; Jung EJ; Kim MA; Nam KT; Goldenring JR; Yang HK; Kim WH
Ann Surg Oncol; 2012 Apr; 19(4):1240-9. PubMed ID: 22048633
[TBL] [Abstract][Full Text] [Related]
14. Expression of trefoil peptides in the subtypes of intestinal metaplasia.
Kim BW; Kim KM; Lee BI; Maeng LS; Choi H; Cho SH; Chae HS; Kim JK; Choi KY; Chung IS
Peptides; 2004 May; 25(5):779-83. PubMed ID: 15177872
[TBL] [Abstract][Full Text] [Related]
15. Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives.
Kuo HY; Chang WL; Yeh YC; Tsai YC; Wu CT; Cheng HC; Yang HB; Lu CC; Sheu BS
Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27220894
[TBL] [Abstract][Full Text] [Related]
16. Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.
Ding A; Zhao W; Shi X; Yao R; Zhou F; Yue L; Liu S; Qiu W
PLoS One; 2013; 8(12):e82136. PubMed ID: 24358147
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Cytotoxic Effect on Gastric Cancer Cells of an Immunotoxin Cocktail in Which Antibodies Recognize Different Epitopes on CDH17.
Kusano-Arai O; Iwanari H; Kudo S; Kikuchi C; Yui A; Akiba H; Matsusaka K; Kaneda A; Fukayama M; Tsumoto K; Hamakubo T
Monoclon Antib Immunodiagn Immunother; 2018 Feb; 37(1):1-11. PubMed ID: 29474162
[TBL] [Abstract][Full Text] [Related]
18. Association between cadherin-17 expression and pathological characteristics of gastric cancer: a meta-analysis.
Long ZW; Zhou ML; Fu JW; Chu XQ; Wang YN
World J Gastroenterol; 2015 Mar; 21(12):3694-705. PubMed ID: 25834338
[TBL] [Abstract][Full Text] [Related]
19. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.
Taniguchi Y; Kurokawa Y; Takahashi T; Mikami J; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
World J Surg; 2018 Dec; 42(12):3997-4004. PubMed ID: 30039286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
